SANgly-M
Description_Effects
SANgly-M is a combination antidiabetic medication containing Gliclazide (80 mg) and Metformin (500 mg), formulated to provide effective blood sugar control in patients with type 2 diabetes mellitus. This dual-action therapy helps manage blood glucose levels more efficiently, especially when lifestyle changes such as diet and exercise alone are not sufficient. Gliclazide is a sulfonylurea that stimulates the pancreas to release more insulin, thereby lowering blood sugar levels. Metformin, a biguanide, works by reducing glucose production in the liver and improving the body’s sensitivity to insulin. Together, they offer a complementary mechanism of action that ensures better glycemic control throughout the day. By maintaining optimal blood sugar levels, SANgly-M not only helps prevent symptoms of high blood glucose (such as fatigue, frequent urination, and excessive thirst) but also reduces the long-term risk of complications like nerve damage, kidney problems, and cardiovascular disease. SANgly-M is best used as part of a comprehensive diabetes management plan, including a balanced diet, regular physical activity, and routine monitoring of blood sugar levels. Always take this medication exactly as prescribed by your doctor to achieve the best therapeutic outcomes.
